整合全球监测、地方行动以及对抗抗菌药物耐药性的创新管理。
Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance.
作者信息
Ruiz-Ramos Jesús
机构信息
Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sat Quintí 77-79, 08041 Barcelona, Spain.
出版信息
Antibiotics (Basel). 2025 Aug 18;14(8):835. doi: 10.3390/antibiotics14080835.
Abstract
The silent pandemic of antimicrobial resistance (AMR) represents one of the gravest threats to global health of the 21st century [...].
摘要
抗菌药物耐药性这一无声的大流行是21世纪全球健康面临的最严重威胁之一[...]。
相似文献
1
Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance.整合全球监测、地方行动以及对抗抗菌药物耐药性的创新管理。
Antibiotics (Basel). 2025 Aug 18;14(8):835. doi: 10.3390/antibiotics14080835.
2
Strengthening Community Antimicrobial Stewardship in Africa: A Systematic Review of the Roles, Challenges, and Opportunities of Community Health and Animal Health Workers.加强非洲社区抗菌药物管理：对社区卫生工作者和动物卫生工作者的作用、挑战及机遇的系统评价
Wellcome Open Res. 2025 Jul 9;10:346. doi: 10.12688/wellcomeopenres.24387.1. eCollection 2025.
3
Korea's National Action Plan on Antimicrobial Resistance: Focusing on the Appropriate Use of Antibiotics.韩国抗菌药物耐药性国家行动计划：聚焦抗生素的合理使用
Infect Chemother. 2025 Jun;57(2):203-214. doi: 10.3947/ic.2025.0028. Epub 2025 May 22.
4
Progress on the Global Research Agenda for Antimicrobial Resistance in Human Health in Pakistan: Findings and Implications.巴基斯坦人类健康领域抗微生物药物耐药性全球研究议程的进展：研究结果与启示
Infect Drug Resist. 2025 Jul 29;18:3795-3828. doi: 10.2147/IDR.S531874. eCollection 2025.
5
Evaluating Jordan's antimicrobial resistance national action plan (2018-2022) implementation: progress and recommendations.评估约旦抗菌药物耐药性国家行动计划（2018 - 2022年）的实施情况：进展与建议
BMC Public Health. 2025 Aug 9;25(1):2718. doi: 10.1186/s12889-025-24073-5.
6
Systems Policy Analysis for Antimicrobial Resistance Targeted Action (SPAARTA): A Research Protocol.抗菌药物耐药性靶向行动的系统政策分析（SPAARTA）：一项研究方案。
Wellcome Open Res. 2025 Jul 30;9:700. doi: 10.12688/wellcomeopenres.22923.2. eCollection 2024.
7
A baseline assessment of antimicrobial stewardship core element implementation in selected public hospitals in Malawi: findings from the 2023 National Program Audit.马拉维部分公立医院抗菌药物管理核心要素实施情况的基线评估：2023年国家项目审计结果
Front Public Health. 2025 Jun 12;13:1588778. doi: 10.3389/fpubh.2025.1588778. eCollection 2025.
8
Antimicrobial resistance of spp. isolated from canine specimens submitted to a veterinary diagnostic laboratory in South Africa.从提交给南非一家兽医诊断实验室的犬类标本中分离出的 spp. 的抗菌药物耐药性。
Vet World. 2025 Jun;18(6):1421-1432. doi: 10.14202/vetworld.2025.1421-1432. Epub 2025 Jun 6.
9
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.与 COVID-19 大流行相关的抗生素耐药性：系统评价和荟萃分析。
Clin Microbiol Infect. 2023 Mar;29(3):302-309. doi: 10.1016/j.cmi.2022.12.006. Epub 2022 Dec 9.
10
Combating antimicrobial resistance in osteoarticular infections: Current strategies and future directions.对抗骨关节炎感染中的抗菌药物耐药性：当前策略与未来方向。
J Clin Orthop Trauma. 2024 Nov 2;58:102791. doi: 10.1016/j.jcot.2024.102791. eCollection 2024 Nov.
本文引用的文献
1
Logistic Stewardship: Supporting Antimicrobial Stewardship Programs Based on Antibiotics Goods Flow.物流管理：基于抗生素物流支持抗菌药物管理计划
Antibiotics (Basel). 2025 Jan 6;14(1):43. doi: 10.3390/antibiotics14010043.
2
A Point Prevalence Survey of Antimicrobial Use in Second-Level Mexican Hospitals: A Multicenter Study.墨西哥二级医院抗菌药物使用情况的现况调查：一项多中心研究
Antibiotics (Basel). 2024 Nov 9;13(11):1065. doi: 10.3390/antibiotics13111065.
3
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.全球细菌对抗菌药物耐药性的负担 1990-2021：一项系统分析及对 2050 年的预测。
Lancet. 2024 Sep 28;404(10459):1199-1226. doi: 10.1016/S0140-6736(24)01867-1. Epub 2024 Sep 16.
4
Examining Antimicrobial Resistance in : A Case Study in Central Virginia's Environment.弗吉尼亚州中部环境中的抗菌药物耐药性研究：一个案例分析
Antibiotics (Basel). 2024 Feb 28;13(3):223. doi: 10.3390/antibiotics13030223.
5
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016-2020.通过重症监护病房和非重症监护病房、感染源及地理区域分析氨曲南-阿维巴坦及对照药物对肠杆菌科细菌的抗菌活性：2016 - 2020年ATLAS项目
Antibiotics (Basel). 2023 Nov 3;12(11):1591. doi: 10.3390/antibiotics12111591.
6
The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department.急诊科抗菌药物管理的干预措施与挑战
Antibiotics (Basel). 2023 Oct 9;12(10):1522. doi: 10.3390/antibiotics12101522.
7
In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019-2020.头孢洛林及对照药物对2019 - 2020年全球皮肤和软组织感染患者分离菌株的体外活性：ATLAS项目
Antibiotics (Basel). 2023 Jul 26;12(8):1237. doi: 10.3390/antibiotics12081237.
Zotero 插件